News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Acceleron Pharma Reports Second Quarter 2014 Financial Results



8/12/2014 8:41:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today provided a corporate update and reported financial results for the second quarter ended June 30, 2014.

“This has been a period of tremendous momentum at Acceleron with the rapid progress and expansion of our clinical pipeline,” said John Knopf, Ph.D., Chief Executive Officer of Acceleron. “We presented encouraging interim clinical data from five different ongoing phase 2 clinical trials across all three of our clinical programs, in particular our hematology programs partnered with Celgene. These results illustrate the significant number of distinct opportunities in our pipeline to generate clinically and commercially promising therapies and we look forward to presenting additional exciting data at major medical conferences later this year.”

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES